Joinn Laboratories (06127) actual controller Zhou Zhiwen reduces 10.10 million shares of the company's stock.
Zhao Yan New Drug (06127) announced that on January 23, 2026, the company received a notification from one of the actual controllers, Zhou Zhiwen, regarding the reduction of the company's shares. Zhou Zhiwen reduced his holdings by a total of 4.1537 million shares through centralized bidding on the Shanghai Stock Exchange from January 22, 2026 to January 23, 2026, representing 0.55% of the company's current total share capital; and by a total of 5.95 million shares through block trading, representing 0.79% of the company's current total share capital. Following this equity change, the shareholding percentage of actual controllers Zhou Zhiwen and Feng Yuxia decreased from 32.27% to 30.93%, triggering a 1% scale change in equity.
Joinn Laboratories (06127) announced that on January 23, 2026, the company received a notification from one of the actual controlling shareholders, Zhou Zhiwen, regarding the reduction of company shares. Zhou Zhiwen sold a total of 4.1537 million shares through the Shanghai Stock Exchange by centralized bidding method between January 22, 2026 and January 23, 2026, representing 0.55% of the company's current total share capital; and sold a total of 5.95 million shares through block trading, representing 0.79% of the company's current total share capital. After this equity change, the shareholding proportion of actual controlling shareholders Zhou Zhiwen and Feng Yuxia decreased from 32.27% to 30.93%, reaching the 1% threshold for equity changes.
Related Articles

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.

CHINA ITS (01900) subsidiary redeeming private equity fund interests
SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RIMAG GROUP (02522) has issued 6.13 million H shares of bonus shares.

CHINA ITS (01900) subsidiary redeeming private equity fund interests

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


